|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Shattuck Labs, Inc. (STTK) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
41,740,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Shattuck Labs is a clinical-stage biopharmaceutical company engaged in developing dual-sided fusion proteins, including its Agonist Redirected Checkpoint and GADLEN platforms, as classes of biologic medicines capable of multifunctional activity with applications in oncology and inflammatory diseases. Co.'s product candidate SL-172154, which is in Phase 1 clinical trial for the treatment of patients with ovarian cancer. Co.'s second product candidate, SL-279252, which is developed to inhibit the PD-1/PD-L1 interaction and activate the OX40 costimulatory receptor and is in Phase 1 clinical trial in patients with solid tumors and lymphoma. Co. has several compounds in preclinical development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
16,004 |
41,004 |
41,004 |
41,004 |
Total Sell Value |
$168,522 |
$418,522 |
$418,522 |
$418,522 |
Total People Sold |
1 |
2 |
2 |
2 |
Total Sell Transactions |
1 |
2 |
2 |
2 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Green Jeremy |
Director |
|
2024-03-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,425) |
5,615,489 |
|
- |
|
Stout Stephen |
See Remarks |
|
2024-03-06 |
4 |
AS |
$10.53 |
$168,522 |
D/D |
(16,004) |
74,437 |
|
- |
|
Stout Stephen |
See Remarks |
|
2024-03-06 |
4 |
OE |
$3.51 |
$39,380 |
D/D |
11,109 |
85,791 |
|
- |
|
Shukla Abhinav A. |
Chief Technical Officer |
|
2024-01-30 |
4 |
D |
$9.99 |
$22,877 |
D/D |
(2,290) |
79,427 |
|
- |
|
Stout Stephen |
See Remarks |
|
2024-01-30 |
4 |
D |
$9.99 |
$5,924 |
D/D |
(593) |
79,332 |
|
- |
|
Deyoung Casi |
Chief Business Officer |
|
2024-01-30 |
4 |
D |
$9.99 |
$20,060 |
D/D |
(2,008) |
89,489 |
|
- |
|
Pandite Arundathy N. |
Chief Medical Officer |
|
2024-01-30 |
4 |
D |
$9.99 |
$29,171 |
D/D |
(2,920) |
216,360 |
|
- |
|
Shukla Abhinav A. |
Chief Technical Officer |
|
2024-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
33,425 |
81,717 |
|
- |
|
Pandite Arundathy N. |
Chief Medical Officer |
|
2024-01-10 |
4 |
D |
$10.09 |
$30,139 |
D/D |
(2,987) |
219,280 |
|
- |
|
Pandite Arundathy N. |
Chief Medical Officer |
|
2024-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
46,475 |
222,267 |
|
- |
|
Deyoung Casi |
Chief Business Officer |
|
2024-01-10 |
4 |
D |
$10.09 |
$15,972 |
D/D |
(1,583) |
91,497 |
|
- |
|
Deyoung Casi |
Chief Business Officer |
|
2024-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
46,200 |
93,080 |
|
- |
|
Neill Andrew R |
Chief Financial Officer |
|
2024-01-10 |
4 |
S |
$10.00 |
$250,000 |
D/D |
(25,000) |
173,446 |
|
- |
|
Neill Andrew R |
Chief Financial Officer |
|
2024-01-10 |
4 |
D |
$10.09 |
$24,922 |
D/D |
(2,470) |
198,446 |
|
- |
|
Neill Andrew R |
Chief Financial Officer |
|
2024-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
56,500 |
200,916 |
|
- |
|
Stout Stephen |
See Remarks |
|
2024-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
49,050 |
79,925 |
|
- |
|
Stout Stephen |
See Remarks |
|
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
15,900 |
30,875 |
|
- |
|
Pandite Arundathy N. |
Chief Medical Officer |
|
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
37,875 |
175,792 |
|
- |
|
Shukla Abhinav A. |
Chief Technical Officer |
|
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
26,100 |
47,092 |
|
- |
|
Neill Andrew R |
Chief Financial Officer |
|
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
34,925 |
144,416 |
|
- |
|
Deyoung Casi |
Chief Business Officer |
|
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
27,100 |
46,880 |
|
- |
|
Thomson Erin Ator |
General Counsel |
|
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
24,125 |
103,209 |
|
- |
|
Deyoung Casi |
Chief Business Officer |
|
2023-01-10 |
4 |
D |
$3.03 |
$4,796 |
D/D |
(1,583) |
19,780 |
|
- |
|
Shukla Abhinav A. |
Chief Technical Officer |
|
2023-01-10 |
4 |
D |
$3.03 |
$5,857 |
D/D |
(1,933) |
20,992 |
|
- |
|
Pandite Arundathy N. |
Chief Medical Officer |
|
2023-01-10 |
4 |
D |
$3.03 |
$9,051 |
D/D |
(2,987) |
137,917 |
|
- |
|
133 Records found
|
|
Page 1 of 6 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|